Hittu Matta - Concepedia

Author

Hittu Matta

The University of Texas Southwestern Medical Center

Also Known As

H Matta, H. Matta, HITTU MATTA, Hittu Matta, Matta Hittu

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

The University of Texas Southwestern Medical Center University of Southern California UPMC Hillman Cancer Center University of Pittsburgh

About

Hittu Matta is an author at The University of Texas Southwestern Medical Center specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	1.2K
2	Engineering	1	1	45
3	Health Sciences	1	1	38
4	Public Health	1	1	38
5	Biomolecular Engineering	1	1	45

Hittu Matta

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Use of adeno-associated viral vector for delivery of small interfering RNA Raghuvir Singh Tomar, Hittu Matta, Preet M. Chaudhary Oncogene Small Interfering RnaViral ReplicationAdeno-associated Viral VectorImmunologyMolecular Biology	2003	196
Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. Kenichi Harada, Shinichi Toyooka, Narayan Shivapurkar, PubMed ImmunoeditingPathologyCancer BiologyMethylation FrequenciesEpigenetics	2002	195
Activation of alternative NF-κB pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1β-converting enzyme inhibitory protein (vFLIP) Hittu Matta, Preet M. Chaudhary Proceedings of the National Academy of Sciences	2004	179
Constitutive NF-κB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice Priti Chugh, Hittu Matta, Sandra Schamus, Proceedings of the National Academy of Sciences Primary Effusion LymphomaApoptosisImmunologyImmune RegulationPathology	2005	117
Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors Hittu Matta, Bhairavi Tolani, Timothy J. Triche, Oncogene Hematological MalignancyLymphoid NeoplasiaPrimary Effusion LymphomaIkzf1-irf4-myc AxisMedicine	2015	114
Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors Bhairavi Tolani, Vasu Punj, Hittu Matta, Oncogene Lymphoid NeoplasiaMedicineImmunologyPathologyBet Bromodomain Inhibitors	2013	98
Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-κB activation Qinmiao Sun, Hittu Matta, Guifang Lu, Oncogene InflammationHuman Herpesvirus 8CytokineImmune Cell DevelopmentViral Immunity	2006	85
The human herpes virus 8–encoded viral FLICE inhibitory protein protects against growth factor withdrawal–induced apoptosis via NF-κB activation Qinmiao Sun, Hittu Matta, Preet M. Chaudhary Blood	2003	80
Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification Narayan Shivapurkar, Jyotsna Reddy, Hittu Matta, Oncogene Death-inducing Signaling ComplexTumor MicroenvironmentOncogenic AgentMedicineApoptosis	2002	74
The proteasome inhibitor bortezomib (PS-341) inhibits growth and induces apoptosis in primary effusion lymphoma cells Hittu Matta, Preet M. Chaudhary Cancer Biology & Therapy	2005	72

Page 1